rs114036100
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014254.3(RXYLT1):c.469G>A(p.Val157Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00197 in 1,612,092 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_014254.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RXYLT1 | NM_014254.3 | c.469G>A | p.Val157Ile | missense_variant | 4/6 | ENST00000261234.11 | NP_055069.1 | |
RXYLT1 | XM_047428078.1 | c.160G>A | p.Val54Ile | missense_variant | 3/5 | XP_047284034.1 | ||
RXYLT1 | NM_001278237.2 | c.-312G>A | 5_prime_UTR_variant | 4/6 | NP_001265166.1 | |||
RXYLT1 | XM_047428079.1 | c.*18G>A | 3_prime_UTR_variant | 5/5 | XP_047284035.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RXYLT1 | ENST00000261234.11 | c.469G>A | p.Val157Ile | missense_variant | 4/6 | 1 | NM_014254.3 | ENSP00000261234.6 |
Frequencies
GnomAD3 genomes AF: 0.0105 AC: 1591AN: 152104Hom.: 21 Cov.: 31
GnomAD3 exomes AF: 0.00267 AC: 667AN: 249602Hom.: 7 AF XY: 0.00206 AC XY: 278AN XY: 134850
GnomAD4 exome AF: 0.00108 AC: 1576AN: 1459870Hom.: 21 Cov.: 31 AF XY: 0.000959 AC XY: 696AN XY: 726042
GnomAD4 genome AF: 0.0105 AC: 1594AN: 152222Hom.: 21 Cov.: 31 AF XY: 0.0103 AC XY: 764AN XY: 74424
ClinVar
Submissions by phenotype
not specified Benign:4
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 16, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jan 13, 2020 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at